Silo Pharma, Inc.

SILO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Oct 14, 2026 CURRENT REPORT
8-K Oct 2, 2026 CURRENT REPORT
8-K Aug 19, 2026 CURRENT REPORT
8-K Aug 17, 2026 CURRENT REPORT
10-Q Aug 13, 2026 QUARTERLY REPORT
SCHEDULE 13G/A Aug 13, 2026
EFFECT Aug 6, 2026
424B3 Aug 6, 2026 PROSPECTUS
S-8 Jul 31, 2026 REGISTRATION STATEMENT
S-3 Jul 24, 2026 REGISTRATION STATEMENT
D Jul 14, 2026
8-K Jul 13, 2026 CURRENT REPORT
SCHEDULE 13G Jul 8, 2026
ARS Jun 30, 2026 FORM ARS
DEFA14A Jun 30, 2026 DEFINITIVE ADDITIONAL MATERIALS
DEF 14A Jun 30, 2026 DEFINITIVE PROXY STATEMENT
8-K Jun 18, 2026 CURRENT REPORT
PRE 14A Jun 18, 2026 DEFINITIVE PROXY STATEMENT
8-K Jun 3, 2026 CURRENT REPORT
8-K Jun 1, 2026 CURRENT REPORT
10-Q May 14, 2026 QUARTERLY REPORT
424B3 Apr 16, 2026 PROSPECTUS
EFFECT Apr 15, 2026
424B3 Apr 14, 2026 PROSPECTUS
POS AM Apr 14, 2026 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1
← Newer Page 1 of 16 · 378 filings Older →